SLIT3 and lung cancer: Hypermethylation of SLIT2 and SLIT3 occurred in 29 (69.0%) and 23 (54.8%) of 42 NSCLCs, respectively, consistent with previous findings reporting that the frequency of SLIT3 methylation in lung cancer was less than that of SLIT2 (20, 22).